Intermittent exotropia, overcorrecting minus lenses, and the Newcastle Scoring System

被引:32
|
作者
Watts, P [1 ]
Tippings, E
Al-Madfai, H
机构
[1] Univ Wales Hosp, Cardiff CF14 4XW, S Glam, Wales
[2] Univ Glamorgan, Pontypridd CF37 1DL, M Glam, Wales
来源
JOURNAL OF AAPOS | 2005年 / 9卷 / 05期
关键词
D O I
10.1016/j.jaapos.2005.04.010
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: We sought to determine whether the Newcastle Control Score (NCS) could be used to indicate a successful outcome in patients with intermittent exotropia that were treated with minus lenses. Methods: We studied patients with an intermittent exotropia who were prescribed minus lens therapy in an effort to manage their strabismus conservatively. The NCS, which quantitatively estimates the control of an intermittent exotropia, was applied before treatment and 4 months after treatment. The results of minus lens therapy with a pretreatment NCS of >= 5 (group 1) were compared with those with a NCS of :: 4 (group 2). Results: There were 24 patients (13 girls, 11 boys) treated with minus lenses. The mean age of the patients was 6.8 +/- 3.8 years (range, 2-17 years; median, 5). The mean pretreatment distance angle was 28.5 +/- 10 prism diopters (range, 6-45; median, 30) and the mean post-treatment distance angle was 18.3 +/- 8.9 prism diopters (range, 0-35; median, 18) P = 0.001. Using the NCS minus lenses significantly (P = 0.041) improved control of exotropia. In group 2 (n = 16) 75% had improved scores post-treatment compared with 62.5% in group 1 (n = 8), P = 0.68. Conclusions: These data suggest that the NCS is a useful method to indicate the success in the control of intermittent exotropia with conservative treatment with minus lens therapy.
引用
收藏
页码:460 / 464
页数:5
相关论文
共 26 条
  • [1] Intervention for intermittent distance exotropia with overcorrecting minus lenses
    Rowe, F. J.
    Noonan, C. P.
    Freeman, G.
    DeBell, J.
    [J]. EYE, 2009, 23 (02) : 320 - 325
  • [2] Intervention for intermittent distance exotropia with overcorrecting minus lenses
    F J Rowe
    C P Noonan
    G Freeman
    J DeBell
    [J]. Eye, 2009, 23 : 320 - 325
  • [3] OVERCORRECTING MINUS LENS THERAPY FOR TREATMENT OF INTERMITTENT EXOTROPIA
    CALTRIDER, N
    JAMPOLSKY, A
    [J]. OPHTHALMOLOGY, 1983, 90 (10) : 1160 - 1165
  • [4] Does overcorrecting minus lens therapy for intermittent exotropia cause myopia?
    Kushner, BJ
    [J]. ARCHIVES OF OPHTHALMOLOGY, 1999, 117 (05) : 638 - 642
  • [5] Overcorrecting minus lens therapy in patients with intermittent exotropia: Should it be the first therapeutic choice?
    Bayramlar, Huseyin
    Gurturk, Ayse Y.
    Sari, Unsal
    Karadag, Remzi
    [J]. INTERNATIONAL OPHTHALMOLOGY, 2017, 37 (02) : 385 - 390
  • [6] Overcorrecting minus lens therapy in patients with intermittent exotropia: Should it be the first therapeutic choice?
    Huseyin Bayramlar
    Ayse Y. Gurturk
    Unsal Sari
    Remzi Karadag
    [J]. International Ophthalmology, 2017, 37 : 385 - 390
  • [7] Role of Overcorrecting Minus Lens Therapy in Intermittent Exotropia for Prevention of Constant Exotropia in Children Under the Age of 7 Years
    Alizadeh, Yousef
    Medghalchi, Abdolreza
    Soltanipour, Soheil
    Mohammadi, Mohammad J.
    Soltani-Moghadam, Reza
    Behboudi, Hassan
    Azaripour, Ebrahim
    Soleimani, Altinai
    [J]. INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2023, 14 (01) : 80
  • [8] The use of distance stereoacuity assessment in determining the effectiveness of minus lenses in intermittent exotropia
    Koklanis, Konstandina
    Georgievski, Zoran
    Zhang, Karen
    [J]. JOURNAL OF AAPOS, 2010, 14 (06): : 488 - 493
  • [9] The use of the Newcastle Control Score in the management of intermittent exotropia
    Buck, Deborah
    Hatt, Sarah R.
    Haggerty, Helen
    Hrisos, Susan
    Strong, Nicholas P.
    Steen, Nicholas I.
    Clarke, Michael P.
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2007, 91 (02) : 215 - 218
  • [10] Is there an optimal minus lens power to help manage intermittent exotropia?
    McClatchey, Scott K.
    [J]. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 50 (04): : 369 - 370